SHR0410
/ Jiangsu Hengrui Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 13
Of
13
Go to page
1
June 27, 2025
A Trial of SHR0410 Injection in Postsurgical Pain Management
(clinicaltrials.gov)
- P2 | N=31 | Terminated | Sponsor: Jiangsu HengRui Medicine Co., Ltd. | N=108 ➔ 31 | Recruiting ➔ Terminated; Adjustment of R&D strategy
Enrollment change • Trial termination • Orthopedics • Pain
August 18, 2022
A Study of SHR4010 in Patients With Hemodialysis
(clinicaltrials.gov)
- P1 | N=12 | Completed | Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Unknown status ➔ Completed
Trial completion • Dermatology • Pruritus • Renal Disease
August 22, 2022
A Trial of SHR0410 Injection in Postsurgical Pain Management
(clinicaltrials.gov)
- P2 | N=108 | Recruiting | Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Not yet recruiting ➔ Recruiting
Enrollment open • Orthopedics • Pain
July 23, 2022
A Clinical Study of the Combination of SHR8554 Injection and SHR0410 Injection for the Treatment of Pain After Abdominal Surgery.
(clinicaltrials.gov)
- P2 | N=108 | Not yet recruiting | Sponsor: Jiangsu HengRui Medicine Co., Ltd.
New P2 trial • Pain
July 14, 2022
A Trial of SHR0410 Injection for the Treatment of Pain After Laparoscopic Surgery
(clinicaltrials.gov)
- P3 | N=357 | Not yet recruiting | Sponsor: Jiangsu HengRui Medicine Co., Ltd.
New P3 trial • Pain
May 27, 2022
A Trial of SHR0410 Injection in Postsurgical Pain Management
(clinicaltrials.gov)
- P2 | N=108 | Not yet recruiting | Sponsor: Jiangsu HengRui Medicine Co., Ltd.
New P2 trial • Orthopedics • Pain
February 10, 2022
A Trial of SHR0410 Injection for the Treatment of Pain After Endoscopic Surgery of the Lower Abdominal
(clinicaltrials.gov)
- P3 | N=228 | Completed | Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Not yet recruiting ➔ Completed | Trial completion date: Dec 2021 ➔ Jul 2021
Trial completion • Trial completion date • Pain
April 21, 2021
A Trial of SHR0410 Injection for the Treatment of Pain After Endoscopic Surgery of the Lower Abdominal
(clinicaltrials.gov)
- P3; N=225; Not yet recruiting; Sponsor: Jiangsu HengRui Medicine Co., Ltd.
New P3 trial • Pain
July 10, 2020
A Trial of SHR0410 Injection in Hemodialysis Participants.
(clinicaltrials.gov)
- P1; N=8; Completed; Sponsor: Atridia Pty Ltd.; Recruiting ➔ Completed; N=24 ➔ 8
Clinical • Enrollment change • Trial completion • Dermatology • Pruritus
May 22, 2020
A Study of SHR4010 in Patients With Hemodialysis
(clinicaltrials.gov)
- P1; N=12; Active, not recruiting; Sponsor: Jiangsu HengRui Medicine Co., Ltd.; Recruiting ➔ Active, not recruiting; Trial completion date: Nov 2019 ➔ May 2020; Trial primary completion date: Sep 2019 ➔ Apr 2020
Clinical • Enrollment closed • Trial completion date • Trial primary completion date • Dermatology • Pruritus
May 22, 2020
A Study of SHR0410 in Hemodialysis Patients With Pruritus
(clinicaltrials.gov)
- P1; N=54; Recruiting; Sponsor: Jiangsu HengRui Medicine Co., Ltd.; Not yet recruiting ➔ Recruiting
Clinical • Enrollment open • Dermatology • Pruritus
March 23, 2020
A Study of SHR0410 in Hemodialysis Patients With Pruritus
(clinicaltrials.gov)
- P1; N=54; Not yet recruiting; Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Clinical • New P1 trial
September 23, 2019
A Study of SHR4010 in Patients With Hemodialysis
(clinicaltrials.gov)
- P1; N=12; Recruiting; Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Clinical • New P1 trial
1 to 13
Of
13
Go to page
1